This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1990 Apr-Jun;4(2):84-5.

doi: 10.1016/0891-6632(90)90042-4.

Microalbuminuria and ACE inhibition in non-hypertensive diabetics

M Marre¹

Affiliations

PMID: 2145309
DOI: 10.1016/0891-6632(90)90042-4

Microalbuminuria and ACE inhibition in non-hypertensive diabetics

M Marre. J Diabet Complications. 1990 Apr-Jun.

. 1990 Apr-Jun;4(2):84-5.

doi: 10.1016/0891-6632(90)90042-4.

Author

M Marre¹

Affiliation

¹ Unité de Diabétologie, Centre Hospitalier Régional Universitaire, Angers, France.

PMID: 2145309
DOI: 10.1016/0891-6632(90)90042-4

No abstract available

PubMed Disclaimer

Similar articles

[In the DETAIL. Kidney protection in manifestations of microalbuminuria].
[No authors listed] [No authors listed] MMW Fortschr Med. 2006 Jun 29;148(26):51. MMW Fortschr Med. 2006. PMID: 16875382 German. No abstract available.
Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J, Siddiqui MA, Ahmad H. Ahmad J, et al. Diabetes Care. 1997 Oct;20(10):1576-81. doi: 10.2337/diacare.20.10.1576. Diabetes Care. 1997. PMID: 9314638 Clinical Trial.
Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
Barnett AH. Barnett AH. Acta Diabetol. 2005 Apr;42 Suppl 1:S42-9. doi: 10.1007/s00592-005-0180-4. Acta Diabetol. 2005. PMID: 15868119 Review.
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Marre M, et al. BMJ. 1988 Oct 29;297(6656):1092-5. doi: 10.1136/bmj.297.6656.1092. BMJ. 1988. PMID: 2848604 Free PMC article. Clinical Trial.
The antiproteinuric effects of blood pressure-lowering agents: differences between nondiabetics and diabetics.
de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D. de Jong PE, et al. J Cardiovasc Pharmacol. 1992;19 Suppl 6:S28-32. doi: 10.1097/00005344-199219006-00006. J Cardiovasc Pharmacol. 1992. PMID: 1382162 Review.

See all similar articles

Cited by

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.
Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC. Strippoli GF, et al. Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006257. doi: 10.1002/14651858.CD006257. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2024 Apr 29;4:CD006257. doi: 10.1002/14651858.CD006257.pub2. PMID: 17054288 Free PMC article. Updated.
Renoprotective role of ACE inhibitors in diabetic nephropathy.
Mogensen CE. Mogensen CE. Br Heart J. 1994 Sep;72(3 Suppl):S38-45. doi: 10.1136/hrt.72.3_suppl.s38. Br Heart J. 1994. PMID: 7946802 Free PMC article. Review. No abstract available.
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease.
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF. Natale P, et al. Cochrane Database Syst Rev. 2024 Apr 29;4(4):CD006257. doi: 10.1002/14651858.CD006257.pub2. Cochrane Database Syst Rev. 2024. PMID: 38682786 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal